Pharma Journalist -

CASI  Pharmaceuticals, committed to ushering in quality pharmaceutical products to the Chinese and U.S markets proclaimed that it has obtained a portfolio of 25 U.S FDA- approved…
Read More...

Behavioral health and addiction recovery center in Houston, Texas, Sacred Oak Medical Center rescinds agreement with RedShift Healthcare Management, LLC with effect from immediate…
Read More...

Perrigo Company asserted that it sought tentative approval from the U.S Food and Drug Administration for the generic version of Onexton Gel (clindamycin phosphate 1.2% and benzoyl…
Read More...

Advanced Accelerator Applications which is a subsidiary of Novartis Groupe S.A sought U.S Food and Drug administration's assent for its New drug application (NDA) for  Lutathera …
Read More...

Stryker's Wingspan StEnt System Post Market SurvEillance Study ( WEAVE Trial) as presented at the International Stroke Conference, testified the results for endovascular treatment with…
Read More...

Novartis proclaimed a licensing agreement with Spark Therapeutics encompassing development, registration and commercialization rights to voretigene neparvovec in markets outside the US.…
Read More...

With a view to addressing a $1.8 billion market globally, and a European market estimated to exceed $500 million, TechCare Corporation a technology company with a revolutionary delivery…
Read More...

Developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, TECHLAB sought U.S FDA's clearance for the CAMPYLOBACTER QUIK CHEK and the CAMPYLOBACTER…
Read More...

The company focused on the development of Conditionally Active Biologic (CAB) protein therapeutics, BioAtla asserted that the U.S FDA has cleared Investigational New Drug application…
Read More...

Leading provider of clinical trial support services, Paragon International affirmed new name "Paragon Global CRS" The name symbolizes the variety of services currently being offered by…
Read More...